ロード中...
下调βⅢ-tubulin逆转肺腺癌A549/Taxol细胞株紫杉醇耐药
BACKGROUND AND OBJECTIVE: Chemotherapy drug resistance is the primary causes of death in patients with pulmonary carcinoma which make tumor recurrence or metastasis.β-tubulin is the main cell targets of anti-microtubule drug.Increased expression of βⅢ-tubulin has been implicated in non-small cell lu...
保存先:
| 出版年: | Zhongguo Fei Ai Za Zhi |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
中国肺癌杂志编辑部
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000364/ https://ncbi.nlm.nih.gov/pubmed/25130963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2014.08.01 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|